NEW YORK (GenomeWeb News) – CLC Bio has developed a software plug-in to work with Symphogen's antibody identification system, the Danish informatics company said today.
CLC developed a plug-in for its Main Workbench that is aimed at optimizing Symphogen’s Symplex technology for high-throughput antibody identification.
Jannick Bendsten, CLC Bio’s director of consulting services, said that the new plug-in is designed to analyze sequencing data coming from research projects conducted using the Symplex system, and to integrate that data into an end-to-end workflow.
Financial terms of the agreement were not released.